24
Participants
Start Date
April 17, 2019
Primary Completion Date
August 28, 2019
Study Completion Date
August 28, 2019
HIP1601 40mg
Single dosing of HIP1601 40mg, orally
Seoul National University Biomedical Research Institute, Seoul
Lead Sponsor
Hanmi Pharmaceutical Company Limited
INDUSTRY